UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

British journal of haematology, 2004-10, Vol.127 (2), p.165-172

2004

Volltextzugriff (PDF)

Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer

Annals of oncology, 2005-08, Vol.16 (8), p.1297-1304

2005

Volltextzugriff (PDF)

Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa study

Annals of oncology, 2016-07, Vol.27 (7), p.1249-1256

2016

Volltextzugriff (PDF)

Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study

British journal of cancer, 2006-08, Vol.95 (3), p.260-265

2006

Volltextzugriff (PDF)

Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi

The Journal of infectious diseases, 1995-05, Vol.171 (5), p.1258-1265

1995

Volltextzugriff (PDF)

A practical guide to the evaluation and treatment of hemophilia

Blood, 1994-07, Vol.84 (1), p.3-9

1994

Volltextzugriff (PDF)

Acquired free protein S deficiency associated with multiple myeloma: A case report

American journal of hematology, 1996-04, Vol.51 (4), p.319-323

1996

Volltextzugriff (PDF)

In vitro characterization of high purity factor IX concentrates for the treatment of hemophilia B

Thrombosis and haemostasis, 1995-04, Vol.73 (4), p.584-591

1995

Volltextzugriff (PDF)

Immunoaffinity Purification of Factor IX (Christmas Factor) by Using Conformation-Specific Antibodies Directed against the Factor IX-Metal Complex

Proceedings of the National Academy of Sciences - PNAS, 1985-06, Vol.82 (11), p.3879-3883

1985

Volltextzugriff (PDF)

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

The New England journal of medicine, 2003-06, Vol.348 (26), p.2609-2617

2003

Volltextzugriff (PDF)

Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa study super()

Annals of oncology, 2016-07, Vol.27 (7), p.1249-1256

2016

Volltextzugriff (PDF)

Recombinant Blood Clotting Proteins for Hemophilia Therapy

Seminars in thrombosis and hemostasis, 1993-01, Vol.19 (1), p.62-72

1993

Volltextzugriff (PDF)

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial

The lancet oncology, 2013, Vol.14 (1), p.72-80

2013

Volltextzugriff (PDF)

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Leukemia, 2009-06, Vol.23 (6), p.1054-1061

2009

Volltextzugriff (PDF)

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

Blood, 2008-04, Vol.111 (8), p.4022-4028

2008

Volltextzugriff (PDF)

Induction and Concurrent Chemotherapy With High-Dose Thoracic Conformal Radiation Therapy in Unresectable Stage IIIA and IIIB Non–Small-Cell Lung Cancer: A Dose-Escalation Phase I Trial

Journal of clinical oncology, 2004-11, Vol.22 (21), p.4341-4350

2004

Volltextzugriff (PDF)

Will recent innovations in therapy save perceived deficiencies in self-sufficiency policies

Blood coagulation & fibrinolysis, 1994, Vol.5 Suppl 4 (4), p.S81-S84

Limentani, S A

1994

Volltextzugriff (PDF)

A phase I dose-escalation and pharmacokinetic (PK) evaluation of an oral AKT inhibitor, LY2503029 (LY)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e13575-e13575

2011

Volltextzugriff (PDF)

Separation of Human Plasma Factor IX From HTLV-I or HIV by Immunoaffinity Chromatography Using Conformation-Specific Antibodies

Blood, 1987-11, Vol.70 (5), p.1312-1315

1987

Volltextzugriff (PDF)

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

Cancer, 2009-02, Vol.115 (3), p.551-560

2009

Volltextzugriff (PDF)

Bone marrow necrosis in two patients with acute promyelocytic leukemia during treatment with all‐trans retinoic acid

American journal of hematology, 1994-09, Vol.47 (1), p.50-55

1994

Volltextzugriff (PDF)

A randomized, placebo-controlled phase II study of AMG 386 plus bevacizumab (Bev) and paclitaxel (P) or AMG 386 plus P as first-line therapy in patients (pts) with HER2-negative, locally recurrent or metastatic breast cancer (LR/MBC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.544-544

2011

Volltextzugriff (PDF)

Safety and efficacy of neratinib (HKI-272) in combination with vinorelbine in patients with solid tumors

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e14554-e14554

2009

Volltextzugriff (PDF)

Abstract P5-18-05: Interim Results from a Phase 1b/2a Study of Trastuzumab Emtansine and Docetaxel, With and Without Pertuzumab, in Patients With HER2-Positive Locally Advanced or Metastatic Breast Cancer

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P5-P5-18-05

2012

Volltextzugriff (PDF)

Safety and pharmacokinetics of intravenous VEGF Trap plus FOLFOX4 in a combination phase I clinical trial of patients with advanced solid tumors

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.13061-13061

2006

Volltextzugriff (PDF)

1 – 25 von 349

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(300)
Mit Volltextzugriff
(243)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Modern Language Review
(33)
International Journal Of Psychoanalysis
(32)
Italian Studies
(25)
Journal Of Clinical Oncology
(23)
Physics Letters. B
(17)
Nuclear Physics. B
(15)
Nuovo Cimento
(13)
Blood
(11)
Cancer
(8)
Cancer Research
(8)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer

Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa study

Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study

Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi

A practical guide to the evaluation and treatment of hemophilia

Acquired free protein S deficiency associated with multiple myeloma: A case report

In vitro characterization of high purity factor IX concentrates for the treatment of hemophilia B

Immunoaffinity Purification of Factor IX (Christmas Factor) by Using Conformation-Specific Antibodies Directed against the Factor IX-Metal Complex

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa study super()

Recombinant Blood Clotting Proteins for Hemophilia Therapy

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

Induction and Concurrent Chemotherapy With High-Dose Thoracic Conformal Radiation Therapy in Unresectable Stage IIIA and IIIB Non–Small-Cell Lung Cancer: A Dose-Escalation Phase I Trial

Will recent innovations in therapy save perceived deficiencies in self-sufficiency policies

A phase I dose-escalation and pharmacokinetic (PK) evaluation of an oral AKT inhibitor, LY2503029 (LY)

Separation of Human Plasma Factor IX From HTLV-I or HIV by Immunoaffinity Chromatography Using Conformation-Specific Antibodies

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

Bone marrow necrosis in two patients with acute promyelocytic leukemia during treatment with all‐trans retinoic acid

A randomized, placebo-controlled phase II study of AMG 386 plus bevacizumab (Bev) and paclitaxel (P) or AMG 386 plus P as first-line therapy in patients (pts) with HER2-negative, locally recurrent or metastatic breast cancer (LR/MBC)

Safety and efficacy of neratinib (HKI-272) in combination with vinorelbine in patients with solid tumors

Abstract P5-18-05: Interim Results from a Phase 1b/2a Study of Trastuzumab Emtansine and Docetaxel, With and Without Pertuzumab, in Patients With HER2-Positive Locally Advanced or Metastatic Breast Cancer

Safety and pharmacokinetics of intravenous VEGF Trap plus FOLFOX4 in a combination phase I clinical trial of patients with advanced solid tumors

Suchergebnisse filtern